ASK4PHARMA CONSULTING: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ASK4PHARMA CONSULTING
Largest movements
- Current investments +€394,454
up €394,454 (+37.7%), from €1.0m to €1.4m
- Receivables within one year -€39,972
down €39,972 (-50.4%), from €79,255 to €39,283
of which Trade receivables: -€42,051
- Reserves +€359,756
up €359,756 (+31.7%), from €1.1m to €1.5m
of which Tax-exempt reserves: +€189,450
- Other debts +€28,997
up €28,997 (+57.0%), from €50,892 to €79,889
- Financial income +€35,977
up €35,977 (+185.5%), from €19,390 to €55,367
- Gross operating margin +€34,326
up €34,326 (+7.7%), from €445,002 to €479,328
- Taxes -€14,701
down €14,701 (-10.3%), from €142,119 to €127,418
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,237,708 | €1,610,886 | +€373,178 | +30.2% |
| Fixed assets | 21/28 | €26,048 | €35,759 | +€9,711 | +37.3% |
| Tangible fixed assets | 22/27 | €25,598 | €35,309 | +€9,711 | +37.9% |
| Land and buildings | 22 | €4,562 | €4,145 | -€417 | -9.1% |
| Furniture and vehicles | 24 | €21,036 | €31,164 | +€10,128 | +48.1% |
| Financial fixed assets | 28 | €450 | €450 | = | 0.0% |
| Current assets | 29/58 | €1,211,660 | €1,575,127 | +€363,467 | +30.0% |
| Amounts receivable within one year | 40/41 | €79,255 | €39,283 | -€39,972 | -50.4% |
| Trade receivables | 40 | €79,255 | €37,204 | -€42,051 | -53.1% |
| Other amounts receivable | 41 | - | €2,079 | +€2,079 | |
| Current investments | 50/53 | €1,047,245 | €1,441,699 | +€394,454 | +37.7% |
| Cash at bank and in hand | 54/58 | €82,058 | €90,571 | +€8,513 | +10.4% |
| Deferred charges and accrued income | 490/1 | €3,102 | €3,574 | +€472 | +15.2% |
| Total equity and liabilities | 10/49 | €1,237,708 | €1,610,886 | +€373,178 | +30.2% |
| Equity | 10/15 | €1,134,161 | €1,493,917 | +€359,756 | +31.7% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €1,133,161 | €1,492,917 | +€359,756 | +31.7% |
| Tax-exempt reserves | 132 | - | €189,450 | +€189,450 | |
| Distributable reserves | 133 | €1,133,161 | €1,303,467 | +€170,306 | +15.0% |
| Amounts payable | 17/49 | €103,547 | €116,969 | +€13,422 | +13.0% |
| Amounts payable within one year | 42/48 | €99,508 | €113,291 | +€13,783 | +13.9% |
| Financial debts | 43 | €2,303 | €5,707 | +€3,404 | +147.8% |
| Credit institutions | 430/8 | €2,303 | €5,707 | +€3,404 | +147.8% |
| Trade debts | 44 | €3,099 | €3 | -€3,096 | -99.9% |
| Suppliers | 440/4 | €3,099 | €3 | -€3,096 | -99.9% |
| Taxes, remuneration and social security | 45 | €43,214 | €27,692 | -€15,522 | -35.9% |
| Taxes | 450/3 | €43,214 | €27,692 | -€15,522 | -35.9% |
| Other amounts payable | 47/48 | €50,892 | €79,889 | +€28,997 | +57.0% |
| Accrued charges and deferred income | 492/3 | €4,039 | €3,678 | -€361 | -8.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,719 | €10,180 | -€539 | -5.0% |
| Other operating charges | 640/8 | €1,813 | €2,464 | +€651 | +35.9% |
| Gross operating margin | 9900 | €445,002 | €479,328 | +€34,326 | +7.7% |
| Operating profit (loss) | 9901 | €432,470 | €466,684 | +€34,214 | +7.9% |
| Financial income | 75/76B | €19,390 | €55,367 | +€35,977 | +185.5% |
| Recurring financial income | 75 | €19,390 | €55,367 | +€35,977 | +185.5% |
| Financial charges | 65/66B | €6,839 | €8,566 | +€1,727 | +25.3% |
| Recurring financial charges | 65 | €6,839 | €8,566 | +€1,727 | +25.3% |
| Profit (loss) for the period before taxes | 9903 | €445,021 | €513,485 | +€68,464 | +15.4% |
| Income taxes | 67/77 | €142,119 | €127,418 | -€14,701 | -10.3% |
| Profit (loss) for the period | 9904 | €302,902 | €386,067 | +€83,165 | +27.5% |
| Transfer to tax-exempt reserves | 689 | - | €189,450 | +€189,450 | |
| Profit (loss) for the period to be appropriated | 9905 | €302,902 | €196,617 | -€106,285 | -35.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.